Literature DB >> 29404750

Acute Limb Ischemia Secondary to Native Artery Occlusion: Results of a Contemporary Case Series.

Nuria Seguí1, Carlos Ruiz-Carmona2,3, Alina Velescu1,4, Eduardo Mateos1, Roberto Elosua5,4, Albert Clará1,6,4.   

Abstract

BACKGROUND: The treatment of acute limb ischemia (ALI) has barely changed over the last years. However, the progressive implementation of anticoagulants, antiplatelet agents or statins within the population might have modified the profile and prognosis of patients suffering an ALI. The aim of this study was to evaluate the current results of the management of ALI secondary to a native artery occlusion.
METHODS: Retrospective study of 220 consecutive patients (mean age 78 years; 49% male) was conducted between 2007 and 2015. ALI secondary to trauma or grafts/stents occlusions were excluded. Statistical analysis was performed with logistic regression.
RESULTS: A total of 141 cases (64.1%) were attributed to embolism and 79 (35.9%) to acute arterial thrombosis. Peripheral neuro-ischemic impairment occurred in 135 patients (61.4%), being severe in 42 (19.1%). ALI treatment included anticoagulation (n = 27; 12.3%), regional fibrinolysis (n = 2; 1%), embolectomy/thrombectomy (n = 129; 58.6%), angioplasty/stenting (n = 8; 3.6%), bypass (n = 47; 21.3%) or direct major limb amputation (n = 7; 3.2%). Limb salvage and survival rates at 30/90 days were 95%/95% and 82.3%/74.1%, respectively. Independent risk factors for major amputation were diabetes, severe neuro-ischemic impairment, acute arterial thrombosis and treatment delay >1 day after vascular consultation. In addition, age, chronic peripheral arterial disease, any neuro-ischemic impairment and a hospitalization for any other reason simultaneous to the ALI were independently associated with mortality.
CONCLUSIONS: Regardless of excellent limb salvage rates, patients currently suffering from an ALI are, when compared to previous studies, older than before and with an increased rate of mortality. Risk factors do not appear to be modifiable once the ALI appears so prevention strategies should be aimed to avoid the episode.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29404750     DOI: 10.1007/s00268-018-4511-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  19 in total

1.  Results of surgical management of acute thromboembolic lower extremity ischemia.

Authors:  Kelly Kempe; Brett Starr; Jeanette M Stafford; Arsalla Islam; Ashley Mooney; Emily Lagergren; Matthew A Corriere; Matthew S Edwards
Journal:  J Vasc Surg       Date:  2014-04-24       Impact factor: 4.268

Review 2.  Atrial fibrillation in the elderly: anticoagulation strategies and indications in the very elderly.

Authors:  Sridar Kamath; Gregory Y H Lip
Journal:  Am J Geriatr Cardiol       Date:  2002 Nov-Dec

3.  Endovascular therapy for acute limb ischemia.

Authors:  Vikram S Kashyap; Ramyar Gilani; James F Bena; Mohsen Bannazadeh; Timur P Sarac
Journal:  J Vasc Surg       Date:  2010-11-03       Impact factor: 4.268

4.  Surgery for acute lower limb ischemia in the elderly population: results of a comparative study.

Authors:  Federico Tosato; Fabio Pilon; Dario Danieli; Francesco Campanile; Massimiliano Zaramella; Domenico Milite
Journal:  Ann Vasc Surg       Date:  2011-05-28       Impact factor: 1.466

5.  Contemporary outcomes of endovascular interventions for acute limb ischemia.

Authors:  Raphael M Byrne; Ashraf G Taha; Efthymios Avgerinos; Luke K Marone; Michel S Makaroun; Rabih A Chaer
Journal:  J Vasc Surg       Date:  2013-12-17       Impact factor: 4.268

6.  Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial.

Authors: 
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

7.  A national and single institutional experience in the contemporary treatment of acute lower extremity ischemia.

Authors:  Jonathan L Eliason; Reid M Wainess; Mary C Proctor; Justin B Dimick; John A Cowan; Gilbert R Upchurch; James C Stanley; Peter K Henke
Journal:  Ann Surg       Date:  2003-09       Impact factor: 12.969

8.  Risk Factors for Long-Term Mortality and Amputation after Open and Endovascular Treatment of Acute Limb Ischemia.

Authors:  Elizabeth A Genovese; Rabih A Chaer; Ashraf G Taha; Luke K Marone; Efthymios Avgerinos; Michel S Makaroun; Donald T Baril
Journal:  Ann Vasc Surg       Date:  2015-11-10       Impact factor: 1.466

9.  Prognostic factors for amputation or death in patients submitted to vascular surgery for acute limb ischemia.

Authors:  Clebes Fagundes; Flávio Danni Fuchs; Almondi Fagundes; Ronaldo A Poerschke; Maurício Z Vacaro
Journal:  Vasc Health Risk Manag       Date:  2005

10.  Patient delay is the main cause of treatment delay in acute limb ischemia: an investigation of pre- and in-hospital time delay.

Authors:  Louise S Londero; Birgitte Nørgaard; Kim Houlind
Journal:  World J Emerg Surg       Date:  2014-11-05       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.